New & Noteworthy

March 2021

Generic Abiraterone Acetate Tablets, USP, 500 mg

Amneal Pharmaceuticals

Amneal Pharmaceuticals releases abiraterone acetate tablets, USP, 250 mg and 500 mg following FDA approval of Amneal’s Abbreviated New Drug Application (ANDA), approved for its use in combination with prednisone. Abiraterone acetate tablets, USP, 250 mg, and 500 mg, are the generic version of Zytiga for the treatment of metastatic prostate cancer. Following approval of the additional 500 mg strength, Amneal has increased commercialization to increase access.

Amneal Pharmaceuticals, Inc

Request More Information

Current Issue